A new drug that works against the main types of primary bone cancer has been developed by researchers at the University of ...
Researchers from Columbia University Irving Medical Center and collaborators applied unbiased scRNA-seq to study Lepr expression in lung mesenchymal cells. To do that, they used a Lepr(creERT2) mouse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback